Chimerix Investor Conference Presentation Deck slide image

Chimerix Investor Conference Presentation Deck

Clinical Efficacy of ONC201 in Recurrent H3 K27M- Mutant Diffuse Midline Glioma Patients Review: Society for Neuro-Oncology 2021 Presentation Isabel Arrillaga-Romany, MD, PhD Massachusetts General Hospital Boston, MA 3
View entire presentation